| Members |
targetComponentId |
| Salmonella tournai |
Salmonella Stockholm var 15+ |
| Salmonella tuebingen |
Salmonella Amager var 15+ |
| Salmonella veddel |
Salmonella II 43:g,t:[1,5] |
| Salmonella wildwood |
Salmonella Meleagridis var 15+, 34+ |
| Salmonella zuerich |
Salmonella II 1,9,12,46,27:c:z39 |
| Salmonella, Subgenus I |
Salmonella enterica subsp. enterica (organism) |
| Salmonella, Subgenus II |
Salmonella enterica subsp. salamae (organism) |
| Salmonella, Subgenus III |
Salmonella enterica subsp. arizonae (organism) |
| Salmonella, Subgenus IV |
Salmonella enterica subsp. houtenae (organism) |
| Salmonella, Subgenus V |
Salmonella bongori (organism) |
| smörgås, livsmedel |
Sandwich (substance) |
| ersättning av fyra eller fler koronarartärer med vena saphena-graft |
Aortocoronary artery bypass of four or more coronary arteries with saphenous vein graft (procedure) |
| ersättning av en koronarartär med vena saphena-graft |
Aortocoronary artery bypass of one coronary artery with saphenous vein graft (procedure) |
| ersättning av tre koronarartärer med vena saphena-graft |
Aortocoronary artery bypass of three coronary arteries with saphenous vein graft (procedure) |
| ersättning av två koronarartärer med vena saphena-graft |
Aortocoronary artery bypass of two coronary arteries with saphenous vein graft (procedure) |
| Saquinavir 500mg tablet |
Saquinavir (as saquinavir mesilate) 500 mg oral tablet |
| Saquinavir mesylate 200mg capsule |
Saquinavir (as saquinavir mesilate) 200 mg oral capsule |
| Saquinavir mesylate 200mg capsule |
Saquinavir (as saquinavir mesilate) 200 mg oral capsule |
| sarkoidos, anulär typ |
Annular sarcoidosis (disorder) |
| sarkom, kategori |
Sarcoma (morphologic abnormality) |
| Sargramostim 250mcg injection |
Product containing precisely sargramostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| satyriasis |
Excessive sexual drive |
| savinasspecifikt extrakt |
Product containing savinase (medicinal product) |
| Scaling |
Desquamation |
| kammussla, livsmedel |
Scallop (substance) |
| Scalpel wound as birth trauma |
Accidental laceration during a procedure |
| skalpellsår orsakat av förlossningstrauma |
Accidental laceration during a procedure |
| Scanning |
Action |
| Scanning-tunnelling |
Action |
| Scapulohumeral fibrositis |
Scapulohumeral fibrositis |
| Scarring |
Scar |
| Schistosome |
Schistosoma |
| Schmidt's syndrome |
Polyglandular autoimmune syndrome, type 2 |
| Schmorl's nodes of other region, NEC |
Schmorl's nodes (disorder) |
| Schonells graderade ordläsningstest |
Schonell graded reading test (assessment scale) |
| Schonells graderade ordstavningstest |
Schonell graded spelling test (assessment scale) |
| School maladjustment |
School maladjustment |
| Scleroderma syndrome |
Systemic sclerosis |
| Scoliosis |
Congenital postural scoliosis |
| skopolamin 0,5 mg/24 timmar, plåster |
Product containing only scopolamine in transdermal dose form (medicinal product form) |
| Scopolamine hydrobromide 0.25% solution |
Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Scopulariopsis koningii |
Scopulariopsis brevicaulis |
| Screwing - action |
Insertion - action (qualifier value) |
| kniper ihop ögonen |
Inappropriate movement of face |
| förvrider ansiktet |
Inappropriate movement of face |
| Scrofula |
Scrofuloderma |
| Sebaceous epithelioma |
Sebaceous adenoma |
| isolerad miljö |
Secluded environment (finding) |
| andra duplexvaccinationen mot difteri och stelkramp |
Administration of second dose of diphtheria and tetanus vaccine |
| Second diphtheria and tetanus double vaccination |
Administration of second dose of diphtheria and tetanus vaccine |
| Second diphtheria, pertussis and tetanus triple vaccination |
Administration of second dose of diphtheria, pertussis, and tetanus vaccine |
| andra trippelvaccinationen mot difteri, kikhosta och stelkramp |
Administration of second dose of diphtheria, pertussis, and tetanus vaccine |
| andra provröret klart |
Second glass clear |
| andra provröret innehåller mukus |
Second glass contains mucous (finding) |
| andra provröret innehåller prickar eller sediment |
Second glass contains specks or sediments |
| andra provröret innehåller trådar eller strängar |
Second glass contains threads or strands |
| Secondary and unspec malig neop pulmonary lymph nodes |
Secondary malignant neoplasm of lymph node |
| Secondary hyperoxaluria |
Secondary oxalosis |
| Secondary hypogonadism |
Hypogonadotropic hypogonadism |
| Secondary localized osteoarthrosis of thigh |
Disorder of lower extremity (disorder) |
| Secondary malignant neoplasm of small intestine and duodenum |
Secondary malignant neoplasm of small intestine (disorder) |
| Secondary malignant neoplastic process |
Neoplasm, metastatic |
| Secondary nephrogenic diabetes insipidus |
Nephrogenic diabetes insipidus |
| sekundärt osteosarkom |
Secondary osteosarcoma following treatment or precursor disease (morphologic abnormality) |
| Secondary syphilis of other viscera |
Secondary syphilis of viscera |
| sekundär transvestism |
Secondary transvestism (finding) |
| sekretin 40 mikrogram, pulver till injektionsvätska, flaska |
Product containing only secretin in parenteral dose form (medicinal product form) |
| Secretory otitis media |
Chronic mucoid otitis media |
| sederande antihistamin |
Histamine receptor antagonist |
| biverkning av sederande antihistamin |
Adverse reaction to antihistamines |
| klinisk handläggningsplan för sjukdom med krampanfall |
Seizure disorder clinical management plan |
| Sejongia antarctica |
Chryseobacterium antarcticum (organism) |
| Sejongia jeonii |
Chryseobacterium jeonii (organism) |
| selegilin 1,25 mg, munsönderfallande tablett |
Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| selegilin 12 mg/24 timmar, depåplåster |
Selegiline 500 microgram/hour prolonged-release transdermal patch |
| selegilin 6 mg/24 timmar, depåplåster |
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| selegilin 9 mg/24 timmar, depåplåster |
Selegiline 375 microgram/hour prolonged-release transdermal patch |
| selen 100 mikrogram/2 ml, oral lösning |
Product containing only selenium in oral dose form (medicinal product form) |
| selen 100 mikrogram/2 ml, injektionsvätska, lösning |
Product containing only selenium in parenteral dose form (medicinal product form) |
| selen 500 mikrogram/10 ml, oral lösning |
Product containing only selenium in oral dose form (medicinal product form) |
| selen 500 mikrogram/10 ml, injektionsvätska, lösning |
Product containing only selenium in parenteral dose form (medicinal product form) |
| seminom, kategori |
Malignant seminoma |
| seminom |
Malignant seminoma |
| senil dermatitis herpetiformis |
Dermatitis herpetiformis |
| Senile dermatitis herpetiformis |
Dermatitis herpetiformis |
| Senna |
Cassia acutifolia |
| senna 7,5 mg/5 ml, sockerfri sirap |
Senna only product in oral dose form |
| senna 7,5 mg/5 ml, oral sirap |
Senna only product in oral dose form |
| senna + isphagula 12,4 %/54,2 % granulat |
Psyllium and senna only product |
| Sensory nerve conduction study for velocity and/or latency |
Sensory nerve conduction study |
| portvaktslymfknuta |
Sentinel lymph node |
| separation av siamesiska tvillingar |
Separation of conjoined twins |
| distorsion i näsans septumbrosk |
Injury of nasal septum |
| Septata |
Encephalitozoon |
| indelning efter organsystem av följdtillstånd efter tidigare sjukdomar |
Disease |
| följdtillstånd efter sjukdom klassificerad efter sjukdomssystem |
Sequelae of disorders (disorder) |
| Serogroup Rift Valley Fever |
Sandfly fever Naples virus |
| Serogroup Sandfly Naples |
Sandfly fever Naples virus |
| Serogroup Sandfly Sicily |
Sandfly fever Sicilian virus (organism) |
| Serotonin uptake inhibitor |
Selective serotonin re-uptake inhibitor |
| seröst blod |
Serous discharge |
FHIR